静脉导管多普勒(11-13+6周)预测印度人群不良胎儿结局的性能:超越非整倍体
该观察性研究纳入2013至2019年间4340例单胎妊娠,评估孕11-13+6周静脉导管多普勒预测不良胎儿结局的性能。静脉导管多普勒异常定义为搏动指数大于相应孕周第95百分位或a波反向,异常者胎儿丢失、非整倍体、心脏缺陷及非心脏结构缺陷发生率均显著高于血流正常者(P < .001)。作者结论认为孕早期静脉导管多普勒可作为心脏缺陷和胎儿死亡的筛查工具,异常者应在18-22周行胎儿超声心动图并在晚孕期行生长扫描及多普勒检查。
要点
- 孕11-13+6周静脉导管多普勒异常定义为搏动指数>相应孕周第95百分位或a波反向。
- 静脉导管多普勒异常者胎儿丢失4.4% vs 正常者0.3%,非整倍体10.2% vs 1.7%(P < .001)。
- 静脉导管多普勒异常者胎儿心脏缺陷5.9% vs 正常者1.4%,非心脏结构缺陷5.4% vs 1.4%(P < .001)。
核心结论
- 孕早期静脉导管多普勒可作为心脏缺陷和胎儿死亡的筛查工具,异常者应接受18-22周胎儿超声心动图及晚孕期生长扫描与多普勒检查。
研究设计与样本
- 观察性研究,纳入2013至2019年间4340例单胎妊娠,于常规孕早期筛查(11-13+6周)行静脉导管多普勒,并随访至分娩。
诊断标准与关键数值
- 静脉导管多普勒异常定义为搏动指数大于相应孕周第95百分位或a波反向;静脉导管多普勒异常患病率为5.12%(205/4004)。
临床应用与阅片要点
- 作者建议静脉导管多普勒异常者应在18-22周行胎儿超声心动图,并在晚孕期行生长扫描及多普勒检查。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The objective of this study is to examine the performance of Ductus venosus (DV) Doppler done at the routine first trimester screening (11-13 + 6 weeks) in predicting the adverse fetal outcomes in Indian population.
METHODS: This observational study was conducted between 2013 and 2019, on 4340 singleton pregnancies. Ductus Doppler were considered abnormal if DV pulsatility index values were >95th centile for that gestation or with a reversed "a" wave. Anatomical survey was done to rule out other abnormalities. Women were followed up till delivery and outcomes were divided into 4 groups: 1) aneuploidies; 2) cardiac defects; 3) non-cardiac structural abnormalities; and 4) miscarriages before 24 weeks or fetal deaths after 24 weeks.
RESULTS: Prevalence of abnormal DV Doppler is 5.12% (205/4004). There were significantly higher number of fetal losses (4.4 versus 0.3%), aneuploidies (10.2 versus 1.7%), fetal cardiac defects (5.9 versus 1.4%), and non-cardiac structural defects (5.4 versus 1.4%) among the pregnancies with abnormal DV Doppler in comparison to those with normal flow (P < .001). Logistic regression analysis has shown that significant contribution to fetal chromosomal abnormalities and cardiac defects was associated with abnormal DV. Other factors which were found to have a significant association with adverse fetal outcome were increased nuchal translucency and increased body mass index (BMI).
CONCLUSION: DV Doppler in first trimester can be used as a screening tool for cardiac defects and fetal deaths. Women with abnormal DV Dopplers should be offered fetal echocardiography at 18-22 weeks and third trimester growth scans with Dopplers.
引用
- Chhikara, Anand, Sharma, et al. Performance of Ductus Venosus Doppler (at 11-13 + 6 Weeks) in Predicting Adverse Fetal Outcomes in Indian Population: Going Beyond Aneuploidies: Going Beyond Aneuploidies. J Ultrasound Med. 2022. PMID: 35274332. doi:10.1002/jum.15976
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。